%0 Journal Article
%T Antibody Targeted Therapies in Meningiomas: A Critical Review
%A Akash kumar
%A Areeba Nisar
%A Eshah Tur Razia
%A Haneen Imran
%A Hira Arshad Jawed
%A Usama Khalid Choudry
%J -
%D 2017
%X Surgical resection being the most successful approach for meningomas is not always possible pertaining to its inapproachable locations of tumors. Radiation therapy is sometimes restricted by neurotoxicity and tumor size, while chemotherapy regimens have been minimally effective as treatment option in meningiomas. Therefore, treatment of the remaining subset of aggressive, unapproachable or refractory meningiomas remains challenging. This makes it a topic of concern to explore more strategies for its management. Recent practices have shown increased interests in the utilization if monoclonal antibodies. Among the most prospective are TRAIL therapy followed by antibodies targeting receptors such as PDGFR, EDGF, VEGFR, PD-1. These therapies can be utilized to reduce the stability of meningiomas. There is a need for initiation of large scale Randomized controlled trials to improve outcomes in meningioma patients and formation of a more productive management strategy.
%K Meningioma
%K Monoclonal antibodies
%K Molecular targeted therapies
%K Disease management
%K In vitro
techniques
%K list of open access journals
%K open access
%K open access journals
%K open access publication
%K open access publisher
%K open access publishing
%K open access journal articles
%K imedpub
%K imedpub publishing
%K insight medical publishing
%K imedpub online
%U https://www.imedpub.com/articles/antibody-targeted-therapies-in-meningiomas-a-critical-review.php?aid=19118